• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Ellen 't Hoen

52 POSTS 0 COMMENTS
http://medicineslawandpolicy.org

Time to put a stop to the abuse of orphan drug regulation- the latest...

Ellen 't Hoen - January 9, 2019

2018 Round-up of Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 26, 2018

New Database Documents the Power of TRIPS Flexibilities

Ellen 't Hoen - November 27, 2018

WIPO and pharma industry launch global medicines patent database

Ellen 't Hoen - September 27, 2018

Dutch health insurance company Menzis takes AstraZeneca to court over patent evergreening

Ellen 't Hoen - September 20, 2018

New Dutch Foundation to Address High Medicines Pricing Announces Plan to File Complaint with...

Ellen 't Hoen - August 25, 2018

Opmerkingen bij de notitie Dwanglicenties van B.J. Bruins, Minister voor Medische Zorg.

Ellen 't Hoen - July 10, 2018

European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to Protect European Patients...

Ellen 't Hoen - May 21, 2018

Brazil’s Federal Court Reviews Medicines Mailbox Patents

Ellen 't Hoen - April 29, 2018

The Power of TRIPS Flexibilities in Medicines Procurement

Ellen 't Hoen - April 9, 2018
1...3456Page 4 of 6
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.